- Home
- CTBI vs ELVN Comparison
CTBI vs ELVN Comparison
Compare CTBI & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTBI
- ELVN
- Stock Information
- Founded
- CTBI 1903
- ELVN 2016
- Country
- CTBI United States
- ELVN United States
- Employees
- CTBI N/A
- ELVN N/A
- Industry
- CTBI Major Banks
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- CTBI Finance
- ELVN Health Care
- Exchange
- CTBI Nasdaq
- ELVN Nasdaq
- Market Cap
- CTBI 959.5M
- ELVN 1.1B
- IPO Year
- CTBI N/A
- ELVN 2020
- Fundamental
- Price
- CTBI $55.41
- ELVN $21.64
- Analyst Decision
- CTBI Buy
- ELVN Strong Buy
- Analyst Count
- CTBI 3
- ELVN 5
- Target Price
- CTBI $59.00
- ELVN $41.20
- AVG Volume (30 Days)
- CTBI 62.0K
- ELVN 617.8K
- Earning Date
- CTBI 10-15-2025
- ELVN 11-12-2025
- Dividend Yield
- CTBI 3.83%
- ELVN N/A
- EPS Growth
- CTBI 17.49
- ELVN N/A
- EPS
- CTBI 5.17
- ELVN N/A
- Revenue
- CTBI $261,447,000.00
- ELVN N/A
- Revenue This Year
- CTBI $21.01
- ELVN N/A
- Revenue Next Year
- CTBI $6.33
- ELVN $20.05
- P/E Ratio
- CTBI $10.71
- ELVN N/A
- Revenue Growth
- CTBI 13.97
- ELVN N/A
- 52 Week Low
- CTBI $44.60
- ELVN $13.30
- 52 Week High
- CTBI $61.67
- ELVN $26.09
- Technical
- Relative Strength Index (RSI)
- CTBI 59.03
- ELVN 56.79
- Support Level
- CTBI $52.55
- ELVN $20.37
- Resistance Level
- CTBI $54.77
- ELVN $23.31
- Average True Range (ATR)
- CTBI 1.04
- ELVN 1.36
- MACD
- CTBI 0.31
- ELVN 0.21
- Stochastic Oscillator
- CTBI 79.88
- ELVN 82.33
About CTBI Community Trust Bancorp Inc.
Community Trust Bancorp Inc is a bank holding company. The Bank owns all the capital stock of one commercial bank and one trust company, serving small and mid-sized communities in eastern, north-eastern, central, and southcentral Kentucky, southern West Virginia, and north-eastern Tennessee. Through its subsidiaries, the Bank is engaged in commercial and personal banking and trust and wealth management activities, which include accepting time and demand deposits; making secured and unsecured loans to corporations, individuals, and others; providing cash management services to corporate and individual customers; issuing letters of credit; renting safe deposit boxes; and providing funds transfer services.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.